This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
1. Barash JR, Tang TWH, Arnon SS. First case of infant botulism caused by Clostridium baratti Type F in California. J Clin Microgiol. 2005; 43:4280–4282.
2. Black JD, Dolly JO. Interaction of I-125 labeled botulinum neurotoxins with nerve terminal. II. Autoradiographic evidence for its intake into motor nerves by acceptor-mediated endocytosis. J Cell Biol. 1986; 103:535.
3. Mitchell WG, Tseng-Ong L. 2005; Catastrophic presentation of infant botulism may obscure or delay diagnosis. Pediatrics. 1986; 116:e436–438.
4. Schreiner MS, Field E, Ruddy R. Infant botulism: a review of 12 years’ experience at the Children's Hospital of Philadelphia. Pediatrics. 1991; 87:159–165.
5. Shapiro RL, Hthaway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med. 1998; 129:221–228.
6. Guiterrez AR, Bodensteiner J, Gutmann L. Electrodiagnosis of infantile botulism. J Child Neurol. 1994; 9:362–365.
7. Arnon SS, Damus K, Thompson B, et al.: Protective role of human milk against sudden death from infant botulism. J Pediatr. 1982; 100:568–573.
8. Arnon SS, Schecter R, Maslanka SE, et al: Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006; 354:462–471.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Stechenberg, B. (2008). Clostridium botulinum. In: The Neurological Manifestations of Pediatric Infectious Diseases and Immunodeficiency Syndromes. Infectious Disease™. Humana Press. https://doi.org/10.1007/978-1-59745-391-2_21
Download citation
DOI: https://doi.org/10.1007/978-1-59745-391-2_21
Publisher Name: Humana Press
Print ISBN: 978-1-58829-967-3
Online ISBN: 978-1-59745-391-2
eBook Packages: MedicineMedicine (R0)